ArticleMuscle & nerve2021

Is cerebrospinal fluid amyloid-β42 a promising biomarker of response to nusinersen in adult spinal muscular atrophy patients?

Alessandro Introna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.